ARCHIVES

Preoperative Drug Combo Benefits HER-2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

The Duke Scandal: NEJM Retracts Potti Paper

March 4, 2011

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

Gallo To Say, For Now, DeVita Says: Core Grants Face Big Cut

March 18, 1988

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999